Biophysics Reports >> 2023, Vol.9 >> Issue (3) : 134 - 145 https://doi.org/10.52601/bpr.2023.230003
 

Synergistic glycolysis disturbance for cancer therapy by a MOF-based nanospoiler

Xuemei Zeng, Yihang Ruan, Lun Wang, Jinpeng Deng, Shuangqian Yan
1 Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou 350117, China
2 The Straits Institute of Flexible Electronics (SIFE, Future Technologies), the Straits Laboratory of Flexible Electronics (SLoFE), Fujian Normal University, Fuzhou 350117, China
 
HTML PDF
 
Abstract

Increased glycolysis for promoting adenosine triphosphate (ATP) generation is one of the hallmarks of cancer. Although reducing glucose intake or depriving cellular glucose can delay the growth of tumors to some extent, their therapeutic efficacy is a highly needed improvement for clinical translation. Herein, we found that mannose synergistic with glucose oxidase (GOx) can induce cell death by ATP inhibition, autophagy activation, and apoptosis protein upgradation. By using biodegradable zeolitic imidazolate frameworks (ZIF-8) as a nanocarrier (denoted as ZIF-8/M&G), the mannose and GOx can accumulate at the tumor site while having no obvious long-term toxicity. At the tumor site, GOx inhibits glycolysis by converting glucose and oxygen to H2O2 and gluconic acid, realizing oxidation therapy and expediting the degradation of the pH-responsive ZIF-8 nanoparticles, respectively. Simultaneously, mannose disturbs sugar metabolism and reduces oxygen consumption, which in turn promotes the GOx oxidation process. The concerted glycolysis inhibition through interactions between mannose and GOx endows ZIF-8/M&G nanospolier with excellent therapeutic efficacy bothin vitro and in vivo. Synergistic glycolysis disturbance by the designed nanospoiler in this work proposes a versatile approach for metabolism disturbance to tumor treatment.

Keywords : Glycolysis disturbance, Energy deprivation, Drug delivery, Zeolitic imidazolate frameworks, Metal-organic frameworks
Corresponding Author(s): Xuemei Zeng,Shuangqian Yan
Issue Date: 30 Jun 2023
 
References:
null Akram M Mini-review on glycolysis and cancer J Cancer Educ 2013 28 3 454 457 Akram M (2013) Mini-review on glycolysis and cancer. J Cancer Educ 28(3): 454?457
null Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan Cell Metab 2015 22 1 86 99 Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M (2015) A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab 22(1): 86?99
null Chen T-T, Yi J-T, Zhao Y-Y, Chu X Biomineralized metal-organic framework nanoparticles enable intracellular delivery and endo-lysosomal release of native active proteins J Am Chem Soc 2018 140 31 9912 9920 Chen T-T, Yi J-T, Zhao Y-Y, Chu X (2018) Biomineralized metal-organic framework nanoparticles enable intracellular delivery and endo-lysosomal release of native active proteins. J Am Chem Soc 140(31): 9912?9920
null Cheng H, Jiang X-Y, Zheng R-R, Zuo S-J, Zhao L-P, Fan G-L, Xie B-R, Yu X-Y, Li S-Y, Zhang X-Z A biomimetic cascade nanoreactor for tumor targeted starvation therapy-amplified chemotherapy Biomaterials 2019 195 75 85 Cheng H, Jiang X-Y, Zheng R-R, Zuo S-J, Zhao L-P, Fan G-L, Xie B-R, Yu X-Y, Li S-Y, Zhang X-Z (2019) A biomimetic cascade nanoreactor for tumor targeted starvation therapy-amplified chemotherapy. Biomaterials 195: 75?85
null DeBerardinis RJ Is cancer a disease of abnormal cellular metabolism? New angles on an old idea Genet Med 2008 10 11 767 777 DeBerardinis RJ (2008) Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med 10(11): 767?777
null DeBerardinis RJ, Chandel NS Fundamentals of cancer metabolism Sci Adv 2016 2 5 e1600200 DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2(5): e1600200. https://doi.org/10.1126/sciadv.1600200
null DeRossi C, Bode L, Eklund EA, Zhang F, Davis JA, Westphal V, Wang L, Borowsky AD, Freeze HH Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accumulation, toxicity, and embryonic lethality J Biol Chem 2006 281 9 5916 5927 DeRossi C, Bode L, Eklund EA, Zhang F, Davis JA, Westphal V, Wang L, Borowsky AD, Freeze HH (2006) Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accumulation, toxicity, and embryonic lethality. J Biol Chem 281(9): 5916?5927
null Di Biase S, Lee C, Brandhorst S, Manes B, Buono R, Cheng C-W, Cacciottolo M, Martin-Montalvo A, de Cabo R, Wei M Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity Cancer Cell 2016 30 1 136 146 Di Biase S, Lee C, Brandhorst S, Manes B, Buono R, Cheng C-W, Cacciottolo M, Martin-Montalvo A, de Cabo R, Wei M (2016) Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell 30(1): 136?146
null Fan W, Lu N, Huang P, Liu Y, Yang Z, Wang S, Yu G, Liu Y, Hu J, He Q Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic cancer starving-like/gas therapy Angew Chem Int Ed Engl 2017 56 5 1229 1233 Fan W, Lu N, Huang P, Liu Y, Yang Z, Wang S, Yu G, Liu Y, Hu J, He Q (2017) Glucose-responsive sequential generation of hydrogen peroxide and nitric oxide for synergistic cancer starving-like/gas therapy. Angew Chem Int Ed Engl 56(5): 1229?1233
null Fan Z, Wang Y, Xiang S, Zuo W, Huang D, Jiang B, Sun H, Yin W, Xie L, Hou Z Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate–mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects J Mater Chem B 2020 8 9 1922 1934 Fan Z, Wang Y, Xiang S, Zuo W, Huang D, Jiang B, Sun H, Yin W, Xie L, Hou Z (2020) Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate–mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects. J Mater Chem B 8(9): 1922?1934
null Fu L-H, Qi C, Lin J, Huang P Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment Chem Soc Rev 2018 47 17 6454 6472 Fu L-H, Qi C, Lin J, Huang P (2018) Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment. Chem Soc Rev 47(17): 6454?6472
null Fu LH, Qi C, Hu YR, Lin J, Huang P Glucose oxidase-instructed multimodal synergistic cancer therapy Adv Mater 2019 32 28 e2003130 Fu LH, Qi C, Hu YR, Lin J, Huang P (2019) Glucose oxidase-instructed multimodal synergistic cancer therapy. Adv Mater 32(28): e2003130. https://doi.org/10.1002/adma.202003130
null Ganapathy-Kanniappan S, Geschwind J-FH Tumor glycolysis as a target for cancer therapy: progress and prospects Mol Cancer 2013 12 1 1 11 Ganapathy-Kanniappan S, Geschwind J-FH (2013) Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer 12(1): 1?11
null Gao L, Chen Q, Gong T, Liu J, Li C Recent advancement of imidazolate framework (ZIF-8) based nanoformulations for synergistic tumor therapy Nanoscale 2019 11 44 21030 21045 Gao L, Chen Q, Gong T, Liu J, Li C (2019) Recent advancement of imidazolate framework (ZIF-8) based nanoformulations for synergistic tumor therapy. Nanoscale 11(44): 21030?21045
null Gillies RJ, Robey I, Gatenby RA Causes and consequences of increased glucose metabolism of cancers J Nucl Med 2008 49 Suppl 2 24S 42S Gillies RJ, Robey I, Gatenby RA (2008) Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49(Suppl 2): 24S?42S
null Gonzalez PS, O’Prey J, Cardaci S, Barthet VJ, Sakamaki J-i, Beaumatin F, Roseweir A, Gay DM, Mackay G, Malviya G Mannose impairs tumour growth and enhances chemotherapy Nature 2018 563 7733 719 723 Gonzalez PS, O’Prey J, Cardaci S, Barthet VJ, Sakamaki J-i, Beaumatin F, Roseweir A, Gay DM, Mackay G, Malviya G (2018) Mannose impairs tumour growth and enhances chemotherapy. Nature 563(7733): 719?723
null null
null Liang K, Ricco R, Doherty CM, Styles MJ, Bell S, Kirby N, Mudie S, Haylock D, Hill AJ, Doonan CJ Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules Nat Commun 2015 6 7240 Liang K, Ricco R, Doherty CM, Styles MJ, Bell S, Kirby N, Mudie S, Haylock D, Hill AJ, Doonan CJ (2015) Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules. Nat Commun 6: 7240. https://doi.org/10.1038/ncomms8240
null null
null Nencioni A, Caffa I, Cortellino S, Longo VD Fasting and cancer: molecular mechanisms and clinical application Nat Rev Cancer 2018 18 11 707 719 Nencioni A, Caffa I, Cortellino S, Longo VD (2018) Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer 18(11): 707?719
null Pavlova NN, Thompson CB The emerging hallmarks of cancer metabolism Cell Metab 2016 23 1 27 47 Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1): 27?47
null Pelicano H, Martin D, Xu R, and, Huang P Glycolysis inhibition for anticancer treatment Oncogene 2006 25 34 4633 4646 Pelicano H, Martin D, Xu R, and, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25(34): 4633?4646
null Poddar A, Conesa JJ, Liang K, Dhakal S, Reineck P, Bryant G, Pereiro E, Ricco R, Amenitsch H, Doonan C Encapsulation, visualization and expression of genes with biomimetically mineralized zeolitic imidazolate framework‐8 (ZIF‐8) Small 2019 15 36 1902268 Poddar A, Conesa JJ, Liang K, Dhakal S, Reineck P, Bryant G, Pereiro E, Ricco R, Amenitsch H, Doonan C (2019) Encapsulation, visualization and expression of genes with biomimetically mineralized zeolitic imidazolate framework‐8 (ZIF‐8). Small 15(36): 1902268. https://doi.org/10.1002/smll.201902268
null Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review Front Pharmacol 2011 2 49 Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P (2011) Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front Pharmacol 2: 49. https://doi.org/10.3389/fphar.2011.00049
null Qian Z, Zhao N, Wang C, Yuan W Injectable self-healing polysaccharide hydrogel loading CuS and pH-responsive DOX@ ZIF-8 nanoparticles for synergistic photothermal-photodynamic-chemo therapy of cancer J Mater Sci Technol 2022 127 10 245 255 Qian Z, Zhao N, Wang C, Yuan W (2022) Injectable self-healing polysaccharide hydrogel loading CuS and pH-responsive DOX@ ZIF-8 nanoparticles for synergistic photothermal-photodynamic-chemo therapy of cancer. J Mater Sci Technol 127(10): 245?255
null Seyfried TN, Shelton LM Cancer as a metabolic disease Nutr Metab 2010 7 1 1 22 Seyfried TN, Shelton LM (2010) Cancer as a metabolic disease. Nutr Metab 7(1): 1?22
null Shaw RJ Glucose metabolism and cancer Curr Opin Cell Biol 2006 18 6 598 608 Shaw RJ (2006) Glucose metabolism and cancer. Curr Opin Cell Biol 18(6): 598?608
null Sun C-Y, Qin C, Wang X-L, Yang G-S, Shao K-Z, Lan Y-Q, Su Z-M, Huang P, Wang C-G, Wang E-B Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle Dalton Trans 2012 41 23 6906 6909 Sun C-Y, Qin C, Wang X-L, Yang G-S, Shao K-Z, Lan Y-Q, Su Z-M, Huang P, Wang C-G, Wang E-B (2012) Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle. Dalton Trans 41(23): 6906?6909
null Sun Q, Bi H, Wang Z, Li C, Wang X, Xu J, Zhu H, Zhao R, He F, Gai S Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy Biomaterials 2019 223 119473 Sun Q, Bi H, Wang Z, Li C, Wang X, Xu J, Zhu H, Zhao R, He F, Gai S (2019) Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy. Biomaterials 223: 119473. https://doi.org/10.1016/j.biomaterials.2019.119473
null Oronsky BT, Oronsky N, Fanger GR, Parker CW, Caroen SZ, Lybeck M, Scicinski JJ Follow the ATP: tumor energy production: a perspective Anti-Cancer Agents Med Chem (Formerly Curr Med Chem-Anti-Cancer Agents) 2014 14 9 1187 1198 Oronsky BT, Oronsky N, Fanger GR, Parker CW, Caroen SZ, Lybeck M, Scicinski JJ (2014) Follow the ATP: tumor energy production: a perspective. Anti-Cancer Agents Med Chem (Formerly Curr Med Chem-Anti-Cancer Agents) 14(9): 1187?1198
null Thorens B, Mueckler M Glucose transporters in the 21st Century Am J Physiol-Endocrinol Metab 2010 298 2 E141 E145 Thorens B, Mueckler M (2010) Glucose transporters in the 21st Century. Am J Physiol-Endocrinol Metab 298(2): E141?E145
null Xu R-h, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia Cancer Res 2005 65 2 613 621 Xu R-h, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P (2005) Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65(2): 613?621
null Yan S, Zeng X, Wang Y, Liu BF Biomineralization of bacteria by a metal–organic framework for therapeutic delivery Adv Healthc Mater 2020 9 12 2000046 Yan S, Zeng X, Wang Y, Liu BF (2020) Biomineralization of bacteria by a metal–organic framework for therapeutic delivery. Adv Healthc Mater 9(12): 2000046. https://doi.org/10.1002/adhm.202000046
null null
null Zhao Y, Butler EB, Tan M Targeting cellular metabolism to improve cancer therapeutics Cell Death Dis 2013 4 3 e532 Zhao Y, Butler EB, Tan M (2013) Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis 4(3): e532. https://doi.org/10.1038/cddis.2013.60